The University of Chicago Header Logo

Connection

Mark K. Ferguson to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Mark K. Ferguson has written about Treatment Outcome.
Mark K. Ferguson
Connection Strength
0.797
Treatment Outcome
  1. Recent Changes in Characteristics of Applicants and Matriculants to Thoracic Surgery Fellowships. Semin Thorac Cardiovasc Surg. 2024 Spring; 36(1):57-64.
    View in: PubMed
    Score: 0.089
  2. Thoracoscopic sympathectomy decreases disease burden in patients with medically refractory ventricular arrhythmias. Interact Cardiovasc Thorac Surg. 2022 05 02; 34(5):783-790.
    View in: PubMed
    Score: 0.088
  3. Knowledge of surgical management of hyperhidrosis among primary care physicians and the general public. Interact Cardiovasc Thorac Surg. 2022 05 02; 34(5):791-798.
    View in: PubMed
    Score: 0.088
  4. A Morphomic Index Is an Independent Predictor of Survival After Lung Cancer Resection. Ann Thorac Surg. 2020 03; 109(3):873-878.
    View in: PubMed
    Score: 0.074
  5. Lung function predicts pulmonary complications regardless of the surgical approach. Ann Thorac Surg. 2015 May; 99(5):1761-7.
    View in: PubMed
    Score: 0.053
  6. Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg. 2014 Apr; 45(4):e94-9; discussion e99.
    View in: PubMed
    Score: 0.049
  7. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. Eur J Cardiothorac Surg. 2012 Mar; 41(3):598-602.
    View in: PubMed
    Score: 0.043
  8. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol. 2010 Aug 14; 16(30):3786-92.
    View in: PubMed
    Score: 0.039
  9. Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008 Nov; 34(5):1085-9.
    View in: PubMed
    Score: 0.034
  10. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008 Apr; 85(4):1158-64; discussion 1164-5.
    View in: PubMed
    Score: 0.033
  11. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004 Nov; 78(5):1783-9.
    View in: PubMed
    Score: 0.026
  12. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):661-9.
    View in: PubMed
    Score: 0.022
  13. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
    View in: PubMed
    Score: 0.020
  14. Transcervical thymectomy. Semin Thorac Cardiovasc Surg. 1999 Jan; 11(1):59-64.
    View in: PubMed
    Score: 0.017
  15. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
    View in: PubMed
    Score: 0.016
  16. Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg. 1996 Aug; 62(2):327-30.
    View in: PubMed
    Score: 0.015
  17. Transcervical thymectomy. Chest Surg Clin N Am. 1996 Feb; 6(1):105-15.
    View in: PubMed
    Score: 0.014
  18. External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†. Eur J Cardiothorac Surg. 2016 Jan; 49(1):333-8.
    View in: PubMed
    Score: 0.013
  19. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
    View in: PubMed
    Score: 0.013
  20. Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
    View in: PubMed
    Score: 0.010
  21. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
    View in: PubMed
    Score: 0.010
  22. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis. Eur J Cardiothorac Surg. 2010 Mar; 37(3):535-9.
    View in: PubMed
    Score: 0.009
  23. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
    View in: PubMed
    Score: 0.008
  24. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
    View in: PubMed
    Score: 0.004
  25. Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis. Ann Oncol. 1998 Jun; 9(6):647-51.
    View in: PubMed
    Score: 0.004
  26. Management of giant paraesophageal hernia. Dis Esophagus. 1997 Jan; 10(1):47-50.
    View in: PubMed
    Score: 0.004
  27. Concomitant chemoradiotherapy for non-small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S253-61.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.